Tevogen Regains Nasdaq Listing Compliance; Stock Up

October 01, 2026 — 02:56 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Tevogen Inc. (TVGN), a healthcare company, said it received notice from Nasdaq on September 29, 2026, confirming that it had regained compliance with the $50 million minimum market value of listed securities requirement for continued listing on the Nasdaq Global Market.

Following the news, TVGN is up 7.70% at $7.13 in after-hours trading.

Earlier this September, the company regained compliance with Nasdaq's minimum market value requirement for publicly held shares.

With both requirements met, the related Nasdaq compliance matters are now closed.

The company operates across three areas: Tevogen Bio, focused on biotechnology; Tevogen.AI, focused on artificial intelligence and technology; and Tevogen Healthcare Services, focused on healthcare services.

TVGN has traded between $3.64 and $39.85 over the last year. The stock closed Wednesday's trade at $6.62, down 2.07%.

For more such biotechstock news visit www.rttnews.com.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Tevogen Regains Nasdaq Listing Compliance; Stock Up

Tags

Latest Articles